1. Home
  2. KNSA vs SSRM Comparison

KNSA vs SSRM Comparison

Compare KNSA & SSRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • SSRM
  • Stock Information
  • Founded
  • KNSA 2015
  • SSRM 1946
  • Country
  • KNSA United Kingdom
  • SSRM United States
  • Employees
  • KNSA N/A
  • SSRM N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • SSRM Precious Metals
  • Sector
  • KNSA Health Care
  • SSRM Industrials
  • Exchange
  • KNSA Nasdaq
  • SSRM Nasdaq
  • Market Cap
  • KNSA 1.9B
  • SSRM 2.2B
  • IPO Year
  • KNSA 2018
  • SSRM 1996
  • Fundamental
  • Price
  • KNSA $27.36
  • SSRM $11.83
  • Analyst Decision
  • KNSA Strong Buy
  • SSRM Buy
  • Analyst Count
  • KNSA 5
  • SSRM 3
  • Target Price
  • KNSA $38.80
  • SSRM $9.93
  • AVG Volume (30 Days)
  • KNSA 474.9K
  • SSRM 2.3M
  • Earning Date
  • KNSA 07-22-2025
  • SSRM 05-06-2025
  • Dividend Yield
  • KNSA N/A
  • SSRM N/A
  • EPS Growth
  • KNSA N/A
  • SSRM N/A
  • EPS
  • KNSA N/A
  • SSRM 0.42
  • Revenue
  • KNSA $481,166,000.00
  • SSRM $1,082,002,000.00
  • Revenue This Year
  • KNSA $37.21
  • SSRM $38.81
  • Revenue Next Year
  • KNSA $5.32
  • SSRM $20.12
  • P/E Ratio
  • KNSA N/A
  • SSRM $28.32
  • Revenue Growth
  • KNSA 59.45
  • SSRM N/A
  • 52 Week Low
  • KNSA $17.38
  • SSRM $4.32
  • 52 Week High
  • KNSA $28.56
  • SSRM $11.89
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 62.48
  • SSRM 61.63
  • Support Level
  • KNSA $26.28
  • SSRM $10.90
  • Resistance Level
  • KNSA $27.90
  • SSRM $11.89
  • Average True Range (ATR)
  • KNSA 0.99
  • SSRM 0.37
  • MACD
  • KNSA -0.07
  • SSRM 0.08
  • Stochastic Oscillator
  • KNSA 82.30
  • SSRM 96.47

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About SSRM SSR Mining Inc.

SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.

Share on Social Networks: